Property Week News, analysis, insight and events for UK property professionals
Biopharmaceutical firm Gilead takes 50,000 sq ft at One Triton Square
Digital Edition: Biopharmaceutical firm Gilead takes 50,000 sq ft at One Triton Square
The latest in a string of deals takes British Land and Royal London Asset Management's recently completed, central London science-focused scheme to 77% let.
Already registered or subscriber? Please log in to continue reading
Want to keep reading?
Unlock your free article — Your gateway to Property Intelligence
Register FREE and enjoy one complimentary article every month, packed with:
- Daily market briefings so you act faster on deals and developments
- Finance insights to manage risk and spot opportunities.
- Expert analysis that informs strategy and builds credibility
- Sector-specific intelligence to identify risks and opportunities.
- Legal and compliance updates to stay on the right side of regulation.
- People moves to keep you connected with industry leaders.
Ready for more? Subscribe today for unlimited access to the UK’s most trusted property intelligence.
Check if you already have access from your company or university